Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Hive is open for 2017 applicants

Posted on June 23rd, 2017 by in Pharma R&D

The hive

It’s been over a year since Elsevier first launched The Hive, and we are inspired by the results that we have seen from this venture. Through frequent blog posts and video interviews, we and everyone who followed the project have been able to see the progress made by the four participating companies: Continue reading “The Hive is open for 2017 applicants” »

Building a balanced search formula for pharmacovigilance and literature monitoring

Posted on March 21st, 2017 by in Pharmacovigilance

Adverse drug reactions are an important risk for patient safety and have significant impact on the costs of health systems. A rise in number of diseases has consequently led to a rise in number of drug consumption, which has also brought about an increase in the number of adverse drug events and drug toxicity cases. Continue reading “Building a balanced search formula for pharmacovigilance and literature monitoring” »

Working to Uncover the Mode of Action

Posted on March 2nd, 2017 by in Pharma R&D

The New Year has brought some new talent into the Myelo Therapeutics team. In January we welcomed Susann, our new postdoctoral researcher. We’re excited to have someone with her experience, which includes studying molecular biology in Dresden and Heidelberg, Continue reading “Working to Uncover the Mode of Action” »

Giving Pharma & Biotech Start-Ups a Leg Up

Posted on February 10th, 2017 by in Pharma R&D

Many of the greatest innovations in the pharma world today are emerging from start-up biotech firms. Acknowledging and empowering these small-but-mighty companies was the simple idea behind The Hive, Continue reading “Giving Pharma & Biotech Start-Ups a Leg Up” »

  1. 1
  2. 2